Martin-O'Neil Cancer Center
Research and Clinical Trials
Improving cancer care through research
The Martin-O’Neil Cancer Center participates in the Clinical Trials Cooperative Group Program sponsored by the National Cancer Institute (NCI). The program supports clinical research studies of new cancer treatments that may improve the quality of life for patients today and the standard of cancer care in the future.
Our access to NCI clinical trials is bolstered by our unique affiliation with the University of California, San Francisco, a top-10 cancer research facility and one of just three facilities in California designated as a Comprehensive Cancer Center by the NCI. Additional clinical trials through the NCI RIB can be opened with a week of inquiry.
Benefits to Clinical Trials:
Clinical trials are research studies that test the effectiveness of new cancer drugs, diagnostic procedures and various cancer therapies. There are several benefits to participation, including:
- Close monitoring of your case by clinical staff
- The assurance that your participation in a trial could help future patients with cancer
- Potential early access to new treatment therapies that are tomorrow’s standards
Types of Clinical Trials:
- Prevention trials test various medicines, vitamins, minerals, supplements and lifestyle changes that may lower the risk of cancer.
- Treatment trials test new treatments-new cancer drugs, new approaches to surgery or radiation therapy, or new combinations of different therapies.
- Screenings and observational trials test the best way to detect cancer, focusing particularly on finding cancer in its early stages.
- Quality of life trials investigate the way to improve the comfort and quality of life for cancer patients
To learn more about clincial trials visit www.clincialtrials.gov